Trump admin won’t cover Ozempic for Medicaid, Medicare patients
The Future of Medicare Coverage for Obesity Medications As the decision by the Trump administration to not extend Medicare Part D or Medicaid coverage for popular weight loss drugs like Ozempic solidifies, it raises significant questions about the future healthcare landscape for millions of Americans grappling with obesity. Cost vs. Benefit: A National Dilemma An … Read more